Chemical probes of Skp2-mediated p27 ubiquitylation and degradation
Author:
Affiliation:
1. Department of Biochemistry and Molecular Pharmacology
2. New York University School of Medicine
3. New York
4. USA
5. Department of Molecular Biology and Biophysics
6. University of Connecticut Health Center
7. Farmington
Abstract
A meta-analysis of Skp2 inhibitors based on bioactivity, structure, and medicinal chemistry was used to identify validated Skp2 pharmaceutical hits.
Funder
National Institutes of Health
Publisher
Royal Society of Chemistry (RSC)
Subject
Pharmaceutical Science,Biochemistry,Drug Discovery,Molecular Medicine,Pharmacology,Organic Chemistry
Link
http://pubs.rsc.org/en/content/articlepdf/2018/MD/C8MD00140E
Reference41 articles.
1. SCF ubiquitin ligase-targeted therapies
2. Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma
3. Bortezomib for the Treatment of Mantle Cell Lymphoma
4. Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature
5. Proteasome Inhibitors in Cancer Therapy: Lessons from the First Decade
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A patent review of SCF E3 ligases inhibitors for cancer:Structural design, pharmacological activities and structure–activity relationship;European Journal of Medicinal Chemistry;2024-11
2. Failure of more than 400 candidate medications in clinical trials before 2020;Alzheimer' s Disease Research Guide;2024
3. Ethanol Extract of Citrus grandis ‘Tomentosa’ Exerts Anticancer Effects by Targeting Skp2/p27 Pathway in Non‐Small Cell Lung Cancer;Molecular Nutrition & Food Research;2023-07-12
4. Emerging approaches to CDK inhibitor development, a structural perspective;RSC Chemical Biology;2023
5. KHSRP modulated cell proliferation and cell cycle via regulating PPP2CA and p27 expression in Wilms tumor;Cellular Signalling;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3